SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 153 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $509,000 | -17.5% | 49,629 | +5.1% | 0.03% | -38.8% |
Q2 2016 | $617,000 | +18.7% | 47,229 | 0.0% | 0.05% | +48.5% |
Q1 2016 | $520,000 | +19.5% | 47,229 | 0.0% | 0.03% | -45.0% |
Q4 2015 | $435,000 | -79.6% | 47,229 | -84.6% | 0.06% | +25.0% |
Q3 2015 | $2,128,000 | -13.2% | 306,637 | +22.9% | 0.05% | -25.0% |
Q2 2015 | $2,451,000 | -0.8% | 249,600 | -10.5% | 0.06% | +4.9% |
Q1 2015 | $2,472,000 | +22.0% | 279,001 | +20.6% | 0.06% | -69.7% |
Q4 2014 | $2,027,000 | +35.9% | 231,400 | +6.8% | 0.20% | +415.4% |
Q3 2014 | $1,492,000 | +31.0% | 216,600 | 0.0% | 0.04% | +30.0% |
Q2 2014 | $1,139,000 | +15.5% | 216,600 | 0.0% | 0.03% | +25.0% |
Q1 2014 | $986,000 | -9.8% | 216,600 | -0.1% | 0.02% | -81.7% |
Q4 2013 | $1,093,000 | +1.7% | 216,800 | +2.2% | 0.13% | +351.7% |
Q3 2013 | $1,075,000 | +5.9% | 212,100 | +3.6% | 0.03% | +11.5% |
Q2 2013 | $1,015,000 | – | 204,700 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|